表紙
市場調査レポート

日本の病院での臨床科学・免疫診断市場

2016-2020 Japan Hospital Clinical Chemistry and Immunodiagnostics Market Forecasts: Reagent and Instrument Supplier Shares, Competitive Strategies, Innovative Technologies, Instrumentation Review

発行 Venture Planning Group 商品コード 258715
出版日 ページ情報 英文 520 Pages
納期: 即日から翌営業日
価格
本日の銀行送金レート: 1USD=102.85円で換算しております。

Local License: 同一事業所内

Back to Top
日本の病院での臨床科学・免疫診断市場 2016-2020 Japan Hospital Clinical Chemistry and Immunodiagnostics Market Forecasts: Reagent and Instrument Supplier Shares, Competitive Strategies, Innovative Technologies, Instrumentation Review
出版日: ページ情報: 英文 520 Pages
概要

当レポートでは、日本の病院検査室での臨床化学・免疫診断関連市場について分析し、市場への様々な影響要因(経済・規制・人口・社会・技術的側面)や、研究開発の最新動向と将来展望、今後5年間の市場動向(試薬・検査機器などの販売量・販売額などの予測値)、主な分析装置の機能比較、主な製品開発機会、主要企業プロファイルなどを調査して、その結果を概略以下の構成でお届けします。

イントロダクション

世界市場と技術概要

  • 主なルーチン臨床化学検査(全30種)
  • 治療薬物モニタリング検査(TDM)(全17種)
  • 内分泌機能検査(全20種)
  • 腫瘍市場と特殊化学検査(全12種)
  • 免疫タンパク検定(全7種)
  • 薬物濫用(全12種)
  • 診断装置レビュー:大〜少量/POC検査装置の運用上の特色と機能(全22社分)
  • 主な体外診断技術とその潜在的用途
    • モノクローナル・ポリクローナル抗体
    • 免疫学的検定
    • タンデム質量分析
    • ITおよびオートメーション
    • ドライケミストリー
    • バイオセンサー

日本市場

  • エグゼクティブ・サマリー
  • 事業環境
  • 市場構造
  • 市場規模・成長率、主要サプライヤーの装置・試薬の売上高および市場シェア

主要製品の開発機会

分散型検査製品の設計基準

代替的な市場普及戦略

  • 内部開発
  • 共同事業協定
  • 大学との契約
  • 分散型検査市場の流通戦略
    • マーケティングのアプローチ
    • 製品の複雑性
    • 顧客の選好
    • 既存のサプライヤー
    • 新規参入サプライヤー
    • 主な種類の流通業者
    • 市場の分類

潜在的な市場参入障壁とリスク

  • 市場の成熟化
  • コスト抑制
  • 競争
  • 技術の限界
  • 特許保護
  • 規制による抑制
  • 分散検査市場の課題

競合企業プロファイル

  • Abbott Laboratories
  • AdnaGen
  • Beckman Coulter/Danaher
  • Biomedical Diagnostics
  • BioMerieux
  • Bio-Rad
  • Dako
  • DiaSorin
  • 栄研化学
  • 富士レビオ
  • Instrumentation Laboratory
  • 協和メデックス
  • Matritech
  • Ortho-Clinical Diagnostics
  • Roche
  • Siemens
  • シスメックス
  • Thermo Fisher
  • 東ソー
  • 和光純薬工業
  • Wallac/PE

図表一覧

このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次
Product Code: VPCC16618

This new report from VPGMarketResearch.com contains 520 pages, 64 tables, and presents a comprehensive analysis of the Japanese hospital clinical chemistry and immunodiagnostics market, including: 

  • Major issues pertaining to the Japanese clinical chemistry and immunodiagnostic hospital laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next ten years. 
  • Five-year volume and sales forecasts for over 100 clinical chemistry, TDM, endocrine, cancer, immunoprotein and abused drug assays performed in Japanese hospitals, including controls, calibrators and consumables. 
  • Five-year volume forecasts for serum, whole blood, plasma, CFS, urine and other specimens.
  • Five-year reagent and instrument sales forecasts. 
  • Review of current instrumentation technologies, and a feature comparison
    of high-, medium-, and low-volume/POC analyzers. 
  • Sales and market shares of leading reagent and instrument suppliers. 
  • Review of current and emerging technologies and their potential market applications. 
  • Product development opportunities for clinical chemistry and immunodiagnostic instruments and consumables. 
  • Profiles of current and emerging suppliers, including their sales, market shares, product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements and business strategies. 
  • Market penetration strategies, entry barriers and risks.

          Contains 520 pages and 64 tables

Table of Contents

Introduction

Worldwide Market and Technology Overview

  • A. Major Routine Chemistry Tests
    • 1. Albumin
    • 2. Alkaline Phosphatase
    • 3. ALT/SGPT
    • 4. Ammonia
    • 5. Amylase
    • 6. AST/SGOT
    • 7. Bilirubin, Total
    • 8. Blood Gases
    • 9. Blood Urea Nitrogen (BUN)
    • 10. Calcium
    • 11. Cardio CRP
    • 12. Cholesterol
    • 13. Cholinesterase
    • 14. CRP
    • 15. Creatinine
    • 16. Electrolytes
      • a. Carbon Dioxide/Bicarbonate
      • b. Chloride
      • c. Potassium
      • d. Sodium
    • 17. Ferritin
    • 18. Fructosamine
    • 19. Gamma-Glutamyl Transpeptidase (GGT)
    • 20. Glucose
    • 21. High Density Lipoprotein (HDL)
    • 22. Homocysteine
    • 23. Iron
    • 24. Lactate Dehydrogenase (LDH)
    • 25. Magnesium
    • 26. Phosphorus
    • 27. Protein
    • 28. Triglycerides
    • 29. Uric Acid
    • 30. Troponin
  • B. Therapeutic Drug Monitoring (TDM)
    • 1. Overview
    • 2. Carbamazepine
    • 3. Cyclosporin
    • 4. Digoxin
    • 5. Everolimus
    • 6. Gentamicin
    • 7. Lamotrigine/Lamictal
    • 8. Levetiracetam
    • 9. Lidocaine
    • 10. Lithium
    • 11. NAPA/Procainamide
    • 12. Phenytoin
    • 13. Quinidine
    • 14. Sirolimus
    • 15. Tacrolimus
    • 16. Theophylline
    • 17. Topirimate
    • 18. Valproic Acid
  • C. Endocrine Function Tests
    • 1. Cortisol
    • 2. Estradiol
    • 3. Follicle-Stimulating Hormone (FSH)
    • 4. Gastrin
    • 5. Growth Hormone/IGF-1
    • 6. Human Chorionic Gonadotropin (HCG)
    • 7. LH
    • 8. Progesterone
    • 9. PTH/IO PTH
    • 10. Prolactin
    • 11. T3
    • 12. T3 Free
    • 13. T3 Uptake
    • 14. T4 (Thyroxine)
    • 15. T4 Free
    • 16. TBG
    • 17. Testosterone
    • 18. Thyroglobulin Ab
    • 19. TPO Ab
    • 20. TSH
  • D. Tumor Markers And Special Chemistry Tests
    • 1. AFP
    • 2. CA 15-3
    • 3. CA 19-9
    • 4. CA 27-29
    • 5. Carcinoembrionic Antigen (CEA)
    • 6. Folate/Folic Acid
    • 7. HCG
    • 8. 25-Hydroxy Vitamin D2 and D3
    • 9. Occult Blood
    • 10. Prostate-Specific Antigen (PSA)
    • 11. Thyroglobulin
    • 12. Vitamin B-12
  • E. Immunoprotein Tests
    • 1. Complement
      • a. C3
      • b. C4
    • 2. Free Light Chains
    • 3. Immunofixation
    • 4. Immunoglobulins (IgA, IgE, IgG, IgM)
    • 5. Haptoglobin
    • 6. Prealbumin
    • 7. Protein Electrophoresis
  • F. Drugs of Abuse
    • 1. Overview
    • 2. Test Methodologies
    • 3. Amphetamines
    • 4. Barbiturates
    • 5. Benzodiazepines
    • 6. Cannabinoids/Marijuana
    • 7. Cocaine
    • 8. Lysergic Acid Diethylamide (LSD)
    • 9. Methadone
    • 10. Methaqualone
    • 11. Opiates
    • 12. Phencyclidine
    • 13. Tricyclic Antidepressants
  • G. Instrumentation Review: Operating Characteristics and Features of High-, Medium-, and Low- Volume/POC Analyzers Manufactured By:
    • Abaxis
    • Abbott
    • Alere/Inverness
    • Alfa Wassermann
    • AMS
    • Awareness Technologies
    • Beckman Coulter/Olympus
    • Binding Site
    • bioMerieux
    • Carolina Chemistries
    • DiaSorin
    • Grifols
    • Horiba
    • Medica
    • Nova Biomedical
    • Ortho-Clinical Diagnostics
    • Polymedco
    • Randox
    • Roche
    • Siemens
    • Tosoh
    • Vital Diagnostics
  • H. Major In Vitro Diagnostic Technologies And Their Potential Applications
    • 1. Monoclonal and Polyclonal Antibodies
    • 2. Immunoassays
      • a. Technological Principle
      • d. Chemiluminescence
      • c. Enzyme Immunoassays (EIA)
        • Overview
        • ELISA
        • EMIT
        • Electrochemical
      • d. Radioimmunoassays (RIA)
      • e. Immunoprecipitation
      • f. Affinity Chromatography
    • 3. Tandem Mass Spec
    • 4. IT and Automation
    • 5. Dry Chemistry
    • 6. Biosensors

Japan

  • A. Executive Summary
  • B. Business Environment
  • C. Market Structure
  • D. Market Size, Growth and Major Suppliers' Instrument and Reagent Sales and Market Shares

Major Product Development Opportunities

Design Criteria for Decentralized Testing Products

Alternative Market Penetration Strategies

  • A. Internal Development
  • B. Collaborative Arrangements
  • C. University Contracts
  • D. Distribution Strategies for Decentralized Testing Markets
    • 1. Marketing Approaches
    • 2. Product Complexity
    • 3. Customer Preference
    • 4. Established Suppliers
    • 5. Emerging Suppliers
    • 6. Major Types of Distributors
    • 7. Market Segmentation

Potential Market Entry Barriers and Risks

  • A. Market Maturity
  • B. Cost Containment
  • C. Competition
  • D. Technological Edge and Limitations
  • E. Patent Protection
  • F. Regulatory Constraints
  • G. Decentralized Testing Market Challenges

Competitive Assessments

  • Abbott Laboratories
  • AdnaGen
  • Beckman Coulter/Danaher
  • Biomedical Diagnostics
  • BioMerieux
  • Bio-Rad
  • Dako
  • DiaSorin
  • Eiken
  • Fujirebio
  • Instrumentation Laboratory
  • Kyowa Medex
  • Matritech
  • Ortho-Clinical Diagnostics
  • Roche
  • Siemens
  • Sysmex
  • Thermo Fisher
  • Tosoh
  • Wako
  • Wallac/PE

List of Tables

  • Major Companies Developing or Marketing Albumin Tests
  • Major Companies Developing or Marketing Alkaline Phosphatase Tests
  • Major Companies Developing or Marketing ALT/SGPT Tests
  • Major Companies Developing or Marketing Amylase Tests
  • Major Companies Developing or Marketing AST/SGOT Tests
  • Major Companies Developing or Marketing Bilirubin Tests
  • Major Companies Developing or Marketing Blood Gas Analyzers
  • Major Companies Developing or Marketing BUN Tests
  • Major Companies Developing or Marketing Calcium Tests
  • Major Companies Developing or Marketing Cholesterol Tests
  • Major Companies Developing or Marketing Creatinine Tests
  • Major Companies Developing or Marketing Electrolyte Tests
  • Major Companies Developing or Marketing GGT Tests
  • Major Companies Developing or Marketing Glucose Tests
  • Major Companies Developing or Marketing HDL Tests
  • Major Companies Developing or Marketing Iron Tests
  • Major Companies Developing or Marketing LDH Tests
  • Major Companies Developing or Marketing Magnesium Tests
  • Major Companies Developing or Marketing Phosphorus Tests
  • Major Companies Developing or Marketing Protein Tests
  • Major Companies Developing or Marketing Triglycerides Tests
  • Major Companies Developing or Marketing Uric Acid Tests
  • Major Companies Developing or Marketing TDM Tests
  • Major Companies Developing or Marketing Digoxin Tests
  • Major Companies Developing or Marketing Lithium Tests
  • Major Companies Developing or Marketing Phenytoin Tests
  • Major Companies Developing or Marketing Theophylline Tests
  • Major Companies Developing or Marketing Valproic Acid Tests
  • Major Companies Developing or Marketing FSH Tests
  • Major Companies Developing or Marketing HCG Tests
  • Major Companies Developing or Marketing LH Tests
  • Major Companies Developing or Marketing Prolactin Tests
  • Major Companies Developing or Marketing T3 Tests
  • Major Companies Developing or Marketing T4 Tests
  • Major Companies Developing or Marketing TSH Tests
  • Major Companies Developing or Marketing AFP Tests
  • Major Companies Developing or Marketing CEA Tests
  • Major Companies Developing or Marketing Ferritin Tests
  • Major Companies Developing or Marketing Occult Blood Tests
  • Major Companies Developing or Marketing Prostatic Acid Phosphatase Tests
  • Major Companies Developing or Marketing PSA Tests
  • Major Companies Developing or Marketing Vitamin B-12/Folate Tests
  • Major Companies Developing or Marketing CRP Tests
  • Major Companies Developing or Marketing Drugs of Abuse Tests
  • Major Companies Developing or Marketing Biosensors for Clinical Chemistry Testing
  • Executive Summary Table: Japan, Clinical Chemistry and Immunoassay Test Volume and Diagnostics Sales Forecast By Test Category
  • Japan, Hospital Laboratories Performing Chemistry and Immunoassay Tests By Bed Size
  • Japan, Hospital Laboratories, Profiles, Panels and Individual Tests Forecast
  • Japan, Commercial/Private Laboratories, Profiles, Panels and Individual Tests Forecast
  • Japan, Hospital Laboratories, Routine Chemistry Test Volume Forecast by Assay
  • Japan, Hospital Laboratories, Endocrine Function Test Volume Forecast by Assay
  • Japan, Hospital Laboratories, Tumor Markers and Special Chemistry Test Volume Forecast by Assay
  • Japan, Hospital Laboratories, Immunoprotein Test Volume Forecast by Assay
  • Japan, Hospital Laboratories, TDM Test Volume Forecast by Assay
  • Japan, Hospital Laboratories, Drugs of Abuse Test Volume Forecast by Assay
  • Japan, Clinical Chemistry and Immunoassay Calibrator and Control Market Forecast By Test Category
  • Japan, Hospital Laboratories, Routine Chemistry Reagent Market Forecast by Assay
  • Japan, Hospital Laboratories, Endocrine Function Reagent Market Forecast by Assay
  • Japan, Hospital Laboratories, Tumor Markers and Special Chemistry Reagent Market Forecast by Assay
  • Japan, Hospital Laboratories, Immunoprotein Reagent Market Forecast by Assay
  • Japan, Hospital Laboratories, Drugs of Abuse Reagent Market Forecast by Assay
  • Japan, Clinical Chemistry and Immunoassay Instrument Market Forecast By Analyzer Type
  • Japan, Major Suppliers of Clinical Chemistry Diagnostic Products, Estimated Sales and Market Shares
  • Japan, Major Suppliers of Immunoassay Products, Estimated Sales and Market Shares
Back to Top